新型具有DIVA特性的嵌合C株猪瘟活疫苗的构建与效力
基于猪瘟疫苗C株感染性克隆构建嵌合猪瘟病毒rC/bUTRs-tE2,用牛病毒性腹泻病毒UTR及部分E2区替换C株相应区域。该嵌合病毒在PK15细胞中稳定传代30代,免疫兔和仔猪后诱导CSFV Erns和BVDV tE2抗体阳性血清学特征,仔猪免疫后完全抵抗致死性CSFV攻毒。
要点
- 嵌合病毒rC/bUTRs-tE2在PK15细胞中稳定传代30代,获得稳定生长和遗传特性。
- 与亲本rC/bUTRs-tE2第1代相比,第30代E2出现M834K和M979K两处残基突变。
- 仔猪接种rC/bUTRs-tE2后完全抵抗致死性CSFV攻毒,诱导CSFV Erns和BVDV tE2抗体阳性。
核心结论
- 结果表明rC/bUTRs-tE2是有前景的新型猪瘟标记疫苗候选。
研究设计与样本
- 基于猪瘟疫苗C株感染性cDNA克隆构建嵌合猪瘟病毒,将C株的5'和3'非翻译区及部分E2区(残基690-860)替换为牛病毒性腹泻病毒相应区域,获得嵌合cDNA克隆pC/bUTRs-tE2。
- 将pC/bUTRs-tE2转染PK15细胞并传代获得嵌合病毒rC/bUTRs-tE2,连续传代30代后获得稳定生长和遗传特性。
- 用rC/bUTRs-tE2免疫兔和仔猪,并评估仔猪对致死性CSFV攻毒的保护。
主要发现
- 与亲本rC/bUTRs-tE2第1代相比,rC/bUTRs-tE2第30代E2出现M834K和M979K两处残基突变。
- 与C株相比,rC/bUTRs-tE2细胞嗜性不变,蚀斑形成能力下降。
- 将C株UTR替换为BVDV UTR导致PK15细胞中病毒复制显著增加。
- 与C株诱导的CSFV Erns阳性、BVDV tE2阴性抗体应答相比,rC/bUTRs-tE2免疫兔和仔猪后血清学特征为CSFV Erns和BVDV tE2抗体阳性。
- 仔猪接种rC/bUTRs-tE2后完全抵抗致死性CSFV攻毒。
关键数值与推荐
- 嵌合病毒rC/bUTRs-tE2连续传代30代后获得稳定生长和遗传特性。
- rC/bUTRs-tE2第30代E2出现M834K和M979K两处残基突变。
- 仔猪接种rC/bUTRs-tE2后完全抵抗致死性CSFV攻毒。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To develop the new classical swine fever (CSF) vaccine candidate with differentiating infected vaccinated animals (DIVA) characteristics, a chimeric CSF virus (CSFV) was constructed based on an infectious cDNA clone of the CSF vaccine C-strain. The 5'- and 3'-untranslated regions (UTRs) and partial E2 region (residues 690-860) of the C-strain were substituted with the corresponding regions of bovine viral diarrhoea virus (BVDV) to construct the chimeric cDNA clone pC/bUTRs-tE2. The chimeric virus rC/bUTRs-tE2 was generated by several passages of pC/bUTRs-tE2-transfected PK15 cells. Stable growth and genetic properties of rC/bUTRs-tE2 were obtained after 30 serial passages. Compared to parental rC/bUTRs-tE2 (1st passage), two residue mutations (M834K and M979K) located in E2 in rC/bUTRs-tE2 P30 were observed. Compared to the C-strain, rC/bUTRs-tE2 exhibited unchanged cell tropism and decreased plaque-forming ability. Substituting the C-strain UTRs with the BVDV UTRs resulted in significantly increased viral replication in PK15 cells. Compared to CSFV Erns-positive and BVDV tE2-negative antibody responses induced by the CSF vaccine C-strain, immunization of rabbits and piglets with rC/bUTRs-tE2 resulted in serological profiles of CSFV Erns- and BVDV tE2-positive antibodies, which are used to serologically discriminate pigs that are clinically infected and vaccinated. Vaccination of piglets with rC/bUTRs-tE2 conferred complete protection against lethal CSFV challenge. Our results suggest that rC/bUTRs-tE2 is a promising new CSF marker vaccine candidate.
引用
- Yi W, Wang H, Qin H, et al. Construction and efficacy of a new live chimeric C-strain vaccine with DIVA characteristics against classical swine fever. Vaccine. 2023. PMID: 36803898. doi:10.1016/j.vaccine.2023.02.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。